Although LHRH-NBs manifested no outstanding imaging advantages compared with N-NBs, fluorescence microscopy and immunofluorescence examinations in the present study showed that LHRH-NBs could penetrate through the endothelial gaps, followed by targeting and binding to ovarian cancer cells. This evidence concerns the gene GNRH1 and ovarian carcinoma.